Phytoprophylaxis of infectious complications of gestation in women with chronic pyelonephritis
https://doi.org/10.33667/2078-5631-2019-1-1(376)-76-79
Abstract
In obstetric practice, the search for reserves to increase the effectiveness of prevention of gestational complications associated with infectious and inflammatory diseases of the urinaiy system is relevant. The purpose of this study was to assess the results of using the Canephron® N herbal medicine in pregnant women with chronic pyelonephritis. The study included 100 women, randomly divided into four groups, three of which were carried out for prophylactic use of the drug Canephron®N, and were not prescribed phytoprophylaxis in the fourth. It has been established that monotherapy with Canephron®N reduces the risk of exacerbations of chronic pyelonephritis, improves the functional state of the urinary tract, reduces the incidence of bacteriuria. Optimal results are achieved with the use of prophylactic courses of Canephron®N at the gestational period of 10-12, 22-24, and 34-36 weeks.
About the Authors
A. B. Khuraseva
Kursk State Medical University
Russian Federation
Russian Federation
S. V. Petrov
Medical Center ‘Avicenna’
Russian Federation
Russian Federation
References
1. Аляев ЮГ, Газимиев МА, Еникеев ДВ. Современные аспекты диагностики и лечения гестационного пиелонефрита. Урология. 2008; (1): 3-6
2. Власюк М. Е. и др. Клиническая эффективность консервативной и эндоурологической тактики лечения беременных с острым пиелонефритом при ретенционно-обструктивных осложнениях. РМЖ 2010; 2: 1-9.
3. Hill JB, Sheffield JS, McIntire DD, Wendel GD. Acute pyelonephritis in pregnancy. Obstet. Gynecol. 2005; 105 (1): 18-23.
4. Шехтман ММ. Руководство по экстрагенитальной патологии у беременных.- М.: Триада Х, 2005.
5. Иремашвили ВВ. Инфекции мочевыводящих путей: современный взгляд на проблему. Русский медицинский журнал. 2007; 15 (29): 2231-2236.
6. Каптильный ВА. Современные подходы к диагностике и лечению инфекции мочевыводящих путей во время беременности. Врач. 2007; (11): 74-75.
7. Sharma P, Thapa L. Acute pyelonephritis in pregnancy: a retrospective study. Aust. NZ J. Obstet. Gynec. 2007; 47 (4): 313-5.
8. Pazos Otero N, Fuentes Ricoy L, Ferrandez PB et al. Pyelonephritis and pregnancy. Our experience in a general hospital. An. Med. Interna. 2007; 24 (12): 585-587.
9. Shea K, Hilburger E, BarocoA., Oldfield E. Successful treatment of vancomycin-resistant enterococcus faecium pyelonephritis with daptomycin during pregnancy. Ann. Pharmacother. 2008; (18): 211-218.
10. Kang CI, Kim J, Park DW, et al. Clinical Practice Guidelines for the Antibiotic Treatment of Community-Acquired Urinary Tract Infections. Infect. Chemother. 2018; 50(1): 67-100.
11. Мотин П. И., Пульбере С. Д., Локтев А. В., Абуд М., Атаманова Е. А. Применение препарата Канефрон Н в комплексном лечении больных с острым гестационным пиелонефритом. Клиническая нефрология. 2014; 4: 38-42.
12. Медведь ВИ, Исламова ЕВ. К вопросу о безопасности препарата Канефрон® Н в акушерской практике. Здоровье женщины. 2009; 4 (40): 94-96.
Review
For citations:
Khuraseva A.B., Petrov S.V. Phytoprophylaxis of infectious complications of gestation in women with chronic pyelonephritis. Medical alphabet. 2019;1(1):76-79. (In Russ.) https://doi.org/10.33667/2078-5631-2019-1-1(376)-76-79
Views:
505
Email this article 